Guardant Health Inc (NASDAQ:GH)’s traded shares stood at 3.0 million during the last session, with the company’s beta value hitting 1.16. At the close of trading, the stock’s price was $29.11, to imply a decrease of -3.64% or -$1.1 in intraday trading. The GH share’s 52-week high remains $37.04, putting it -27.24% down since that peak but still an impressive 45.69% since price per share fell to its 52-week low of $15.81. The company has a valuation of $3.60B, with an average of 2.8 million shares in intraday trading volume over the past 10 days and average of 2.12 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Guardant Health Inc (GH), translating to a mean rating of 1.42. Of 13 analyst(s) looking at the stock, 0 analyst(s) give GH a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 13 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.52.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guardant Health Inc (NASDAQ:GH) trade information
After registering a -3.64% downside in the last session, Guardant Health Inc (GH) has traded red over the past five days. The 5-day price performance for the stock is 1.75%, and 40.76% over 30 days. With these gigs, the year-to-date price performance is 7.62%. Short interest in Guardant Health Inc (NASDAQ:GH) saw shorts transact 10.26 million shares and set a 7.41 days time to cover.
The extremes give us $36 and $125 for target low and target high price respectively. As such, GH has been trading -329.41% off suggested target high and -23.67% from its likely low.
Guardant Health Inc (GH) estimates and forecasts
Looking at statistics comparing Guardant Health Inc share performance against respective industry, we note that the company has outperformed competitors. Guardant Health Inc (GH) shares are 10.94% up over the last 6 months, with its year-to-date growth rate higher than industry average at 55.37% against 17.70%. Revenue is forecast to grow 18.53% this quarter before falling -19.13% for the next one. The rating firms project that company’s revenue will grow 28.19% compared to the previous financial year.
Revenue forecast for the current quarter as set by 20 analysts is 186.8M. Meanwhile, for the current quarter, a total of 16 analyst(s) estimate revenue growth to 190.52M.Earnings reports from the last fiscal year show that sales brought in 155.05M and 168.49M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 20.48% before jumping 13.08% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -8.88% for the past 5-year period. While 2024 is set for a 19.46% return in earnings, projections for the next 5 years are at 29.20% annually.
GH Dividends
Guardant Health Inc has its next earnings report out on 2025-Feb-20. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Guardant Health Inc (NASDAQ:GH)’s Major holders
Guardant Health Inc insiders hold 4.56% of total outstanding shares, with institutional holders owning 104.15% of the shares at 109.13% float percentage. In total, 104.15% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 11.64 million shares (or 9.5609% of shares), all amounting to roughly $336.07 million.
The next major institution holding the largest number of shares is BLACKROCK INC. with 11.24 million shares, or about 9.2332% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $324.55 million.
